LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Facility for Span Nihon Kohden Diagnostics Inaugurated in India

By LabMedica International staff writers
Posted on 12 Nov 2008
Span Diagnostics, Ltd. (SDL; Surat, India) and Nihon Kohden Corp. (Tokyo, Japan) announced the formation of a joint venture company called Span Nihon Kohden Diagnostics Pvt Ltd. (SNKDPL).

A manufacturing facility for the newly formed company built at Sachin (Gujarat, India) was inaugurated on October 9, 2008. Officials from both companies present at the opening of the new facility included the chairman of SDL, P. K. Desai M.D. and chairman of Nihon Kohden, Kazuo Ogino.

A few years ago, SDL, in an effort to strengthen its position in the hematology segment, began to distribute Nihon Kohden hematology analyzers in India. Span has already installed more than 1,000 analyzers and has secured its position as one of the top companies in hematology.

SDL produces products for pathology and clinical laboratories in India. These include diagnostic solutions for diseases such as HIV/AIDS, malaria, tuberculosis, and typhoid, as well as reagents for blood banks. Span is also involved in laboratory automation systems for biochemistry, hematology, enzyme-linked immunosorbant assay (ELISA), and allergy testing.

When functioning at its full capacity, the plant will ensure a consistent supply of quality reagents in India.

Related Links:
Span Diagnostics
Nihon Kohden



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Gastrointestinal Panel
Xpert® GI Panel

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
12 Nov 2008  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
12 Nov 2008  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
12 Nov 2008  |   Industry